ACETYLCYSTEINE ALPEX 600 mg for adults, granules for oral solution 10 sachets
Active ingredients: N-acetyl-L-cysteine
Commercialized according to BDPM
Granules for oral solution10 sachetsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACETYLCYSTEINE ALPEX 600 mg ADULTES, granulés pour solution buvable
- Pharmaceutical form
- granulés pour solution buvable
- Route of administration
- orale
- Presentation description
- 10 sachet(s) polytéréphtalate (PET) polyéthylène aluminium PEBDL : polyéthylène à basse densité linéaire
- Marketing authorisation holder
- ALPEX PHARMA (IRL) (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 May 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61406745CIP73012605CIP133400930126059Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTYLCYSTÉINEgranulés | 600 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.